This is the authors' abstract. We don't add key points for this paper.
The β2-adrenergic receptor (β2AR) belongs to the large family of G protein-coupled receptors. Mutation of tyrosine residue 326 to an alanine resulted in a β2AR mutant (β2AR-Y326A) that was defective in its ability to sequester and was less well coupled to adenylyl cyclase than the wild-type β2AR. However, this mutant receptor not only desensitized in response to agonist stimulation but down-regulated normally. In an attempt to understand the basis for the properties of this mutant, we have examined the ability of this regulation-defective mutant to undergo agonist-mediated phosphorylation. When expressed in 293 cells, the maximal response for phosphorylation of the β2AR-Y326A mutant was impaired by 75%. Further characterization of this phosphorylation, using either forskolin stimulation or phosphorylation site-deficient β2AR-Y326A mutants, demonstrated that the β2AR-Y326A mutant can be phosphorylated by cAMP-dependent protein kinase (PKA) but does not serve as a substrate for the β-adrenergic receptor kinase 1 (βARK1). However, overexpression of βARK1 led to the agonist-dependent phosphorylation of the β2AR-Y326A mutant and rescue of its sequestration. βARK1-mediated rescue of β2AR-Y326A sequestration could be prevented by mutating putative βARK phosphorylation sites, but not PKA phosphorylation sites. In addition, both sequestration and phosphorylation of the wild-type β2AR could be attenuated by overexpressing a dominant-negative mutant of βARK1 (C20βARK1-K220M). These findings implicate a role for βARK1-mediated phosphorylation in facilitating wild-type β2AR sequestration. The β2-adrenergic receptor (β2AR) belongs to the large family of G protein-coupled receptors. Mutation of tyrosine residue 326 to an alanine resulted in a β2AR mutant (β2AR-Y326A) that was defective in its ability to sequester and was less well coupled to adenylyl cyclase than the wild-type β2AR. However, this mutant receptor not only desensitized in response to agonist stimulation but down-regulated normally. In an attempt to understand the basis for the properties of this mutant, we have examined the ability of this regulation-defective mutant to undergo agonist-mediated phosphorylation. When expressed in 293 cells, the maximal response for phosphorylation of the β2AR-Y326A mutant was impaired by 75%. Further characterization of this phosphorylation, using either forskolin stimulation or phosphorylation site-deficient β2AR-Y326A mutants, demonstrated that the β2AR-Y326A mutant can be phosphorylated by cAMP-dependent protein kinase (PKA) but does not serve as a substrate for the β-adrenergic receptor kinase 1 (βARK1). However, overexpression of βARK1 led to the agonist-dependent phosphorylation of the β2AR-Y326A mutant and rescue of its sequestration. βARK1-mediated rescue of β2AR-Y326A sequestration could be prevented by mutating putative βARK phosphorylation sites, but not PKA phosphorylation sites. In addition, both sequestration and phosphorylation of the wild-type β2AR could be attenuated by overexpressing a dominant-negative mutant of βARK1 (C20βARK1-K220M). These findings implicate a role for βARK1-mediated phosphorylation in facilitating wild-type β2AR sequestration.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Ferguson et al. (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: